Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Monitoring of visual field over 6 months after active ocular toxoplasmosis.

Blot J, Aptel F, Chumpitazi BFF, Gain P, Vasseneix C, Savy O, Bouillet L, Pelloux H, Chiquet C.

Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1481-1488. doi: 10.1007/s00417-019-04313-2. Epub 2019 Apr 29.

PMID:
31037491
2.

Autochthonous and persistent cutaneous larva migrans in an infant successfully treated by topic albendazole ointment.

Robert MG, Faisant A, Cognet O, Rabodonirina M, Peyron F, Piquemal M, Mazet R, Pelloux H, Brenier-Pinchart MP.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e163-e164. doi: 10.1111/jdv.15356. Epub 2018 Dec 7. No abstract available.

PMID:
30468533
3.

Hypereosinophilia: Biological investigations and etiologies in a French metropolitan university hospital, and proposed approach for diagnostic evaluation.

Peju M, Deroux A, Pelloux H, Bouillet L, Epaulard O.

PLoS One. 2018 Sep 26;13(9):e0204468. doi: 10.1371/journal.pone.0204468. eCollection 2018.

4.

Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.

Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia JMA, Brenier-Pinchart MP, Accoceberry I, Akan H, Abbate I, Boggian K, Bruschi F, Carratalà J, David M, Drgona L, Djurković-Djaković O, Farinas MC, Genco F, Gkrania-Klotsas E, Groll AH, Guy E, Hirzel C, Khanna N, Kurt Ö, Junie LM, Lazzarotto T, Len O, Mueller NJ, Munoz P, Pana ZD, Roilides E, Stajner T, van Delden C, Villena I, Pelloux H, Manuel O.

Emerg Infect Dis. 2018 Aug;24(8):1497-1504. doi: 10.3201/eid2408.180045.

5.

Management of toxoplasmosis in transplant recipients: an update.

Dard C, Marty P, Brenier-Pinchart MP, Garnaud C, Fricker-Hidalgo H, Pelloux H, Pomares C.

Expert Rev Anti Infect Ther. 2018 Jun;16(6):447-460. doi: 10.1080/14787210.2018.1483721. Epub 2018 Jul 2. Review.

PMID:
29855213
6.

Serodiagnosis of Extraintestinal Amebiasis: Retrospective Evaluation of the Diagnostic Performance of the Bordier® ELISA Kit.

Beyls N, Cognet O, Stahl JP, Rogeaux O, Pelloux H.

Korean J Parasitol. 2018 Feb;56(1):71-74. doi: 10.3347/kjp.2018.56.1.71. Epub 2018 Feb 28.

7.

Uncommon and fatal case of cystoisosporiasis in a non HIV-immunosuppressed patient from a non-endemic country.

Post L, Garnaud C, Maubon D, Pelloux H, Mansard C, Bosseray A, Dard C.

Parasitol Int. 2018 Feb;67(1):1-3. doi: 10.1016/j.parint.2017.10.003. Epub 2017 Oct 6.

PMID:
28988952
8.

Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study.

Coron N, Pihet M, Fréalle E, Lemeille Y, Pinel C, Pelloux H, Gargala G, Favennec L, Accoceberry I, Durand-Joly I, Dalle F, Huet F, Fanton A, Boldron A, Loeuille GA, Domblides P, Coltey B, Pin I, Llerena C, Troussier F, Person C, Marguet C, Wizla N, Thumerelle C, Turck D, Bui S, Fayon M, Duhamel A, Prévotat A, Wallaert B, Leroy S, Bouchara JP, Delhaes L.

Mycopathologia. 2018 Feb;183(1):101-117. doi: 10.1007/s11046-017-0173-1. Epub 2017 Jul 26.

PMID:
28748285
9.

Impact of heat-inactivation on anti-Toxoplasma IgM antibody levels.

Brenier-Pinchart MP, Fricker-Hidalgo H, Dard C, Pelloux H.

Clin Chem Lab Med. 2017 Oct 26;55(12):e291-e293. doi: 10.1515/cclm-2017-0209. No abstract available.

PMID:
28708569
10.

Editorial: Parasites in the Tropic-A New Paradigm Shift.

Nissapatorn V, Lau YL, Yazar S, Pelloux H.

Front Immunol. 2017 May 1;8:509. doi: 10.3389/fimmu.2017.00509. eCollection 2017. No abstract available.

11.

Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches.

Peyron F, Mc Leod R, Ajzenberg D, Contopoulos-Ioannidis D, Kieffer F, Mandelbrot L, Sibley LD, Pelloux H, Villena I, Wallon M, Montoya JG.

PLoS Negl Trop Dis. 2017 Feb 16;11(2):e0005222. doi: 10.1371/journal.pntd.0005222. eCollection 2017 Feb. No abstract available.

12.

Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis.

Palencia A, Bougdour A, Brenier-Pinchart MP, Touquet B, Bertini RL, Sensi C, Gay G, Vollaire J, Josserand V, Easom E, Freund YR, Pelloux H, Rosenthal PJ, Cusack S, Hakimi MA.

EMBO Mol Med. 2017 Mar;9(3):385-394. doi: 10.15252/emmm.201607370.

13.

Long-term sera storage does not significantly modify the interpretation of toxoplasmosis serologies.

Dard C, Bailly S, Drouet T, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H.

J Microbiol Methods. 2017 Mar;134:38-45. doi: 10.1016/j.mimet.2017.01.003. Epub 2017 Jan 16.

PMID:
28093212
14.

Interpretation of the Elecsys Toxo IgG avidity results for very low and very high index: study on 741 sera with a determined date of toxoplasmosis.

Fricker-Hidalgo H, L'Ollivier C, Bosson C, Imbert S, Bailly S, Dard C, Piarroux R, Paris L, Pelloux H.

Eur J Clin Microbiol Infect Dis. 2017 May;36(5):847-852. doi: 10.1007/s10096-016-2870-y. Epub 2016 Dec 19.

PMID:
27995345
15.

Late diagnosis of congenital toxoplasmosis based on serological follow-up: A case report.

Dard C, Chemla C, Fricker-Hidalgo H, Brenier-Pinchart MP, Baret M, Mzabi A, Villena I, Pelloux H.

Parasitol Int. 2017 Apr;66(2):186-189. doi: 10.1016/j.parint.2016.12.004. Epub 2016 Dec 9.

PMID:
27956093
16.

Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Villard O, Cimon B, L'Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E.

J Clin Microbiol. 2016 Dec;54(12):3034-3042. Epub 2016 Oct 12.

17.

Relevance of and New Developments in Serology for Toxoplasmosis.

Dard C, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H.

Trends Parasitol. 2016 Jun;32(6):492-506. doi: 10.1016/j.pt.2016.04.001. Epub 2016 May 7. Review.

PMID:
27167666
18.

Prospective Evaluation of a New Aspergillus IgG Enzyme Immunoassay Kit for Diagnosis of Chronic and Allergic Pulmonary Aspergillosis.

Dumollard C, Bailly S, Perriot S, Brenier-Pinchart MP, Saint-Raymond C, Camara B, Gangneux JP, Persat F, Valot S, Grenouillet F, Pelloux H, Pinel C, Cornet M.

J Clin Microbiol. 2016 May;54(5):1236-42. doi: 10.1128/JCM.03261-15. Epub 2016 Feb 17.

19.

Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.

Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF.

J Infect. 2016 Jan;72(1):103-11. doi: 10.1016/j.jinf.2015.09.041. Epub 2015 Oct 28.

PMID:
26518058
20.

Serological diagnosis of Toxoplasma gondii infection: Recommendations from the French National Reference Center for Toxoplasmosis.

Villard O, Cimon B, L'Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E.

Diagn Microbiol Infect Dis. 2016 Jan;84(1):22-33. doi: 10.1016/j.diagmicrobio.2015.09.009. Epub 2015 Sep 18. Review.

21.

Superficial Fungal Infections in a French Teaching Hospital in Grenoble Area: Retrospective Study on 5470 Samples from 2001 to 2011.

Faure-Cognet O, Fricker-Hidalgo H, Pelloux H, Leccia MT.

Mycopathologia. 2016 Feb;181(1-2):59-66. doi: 10.1007/s11046-015-9953-7. Epub 2015 Oct 9.

PMID:
26452757
22.

Contribution of a Simple Bioassay in Effective Therapeutic Drug Monitoring of Posaconazole and Voriconazole.

Tonini J, Bailly S, Gautier-Veyret E, Wambergue C, Pelloux H, Thiébaut-Bertrand A, Cornet M, Stanke-Labesque F, Maubon D.

Ther Drug Monit. 2015 Oct;37(5):685-8. doi: 10.1097/FTD.0000000000000199.

PMID:
26384041
23.

IgG1 anti-cell wall and IgG2 anti-phosphopeptidomannan antibodies in the diagnosis of invasive candidiasis and heavy Candida colonization.

Mattsby-Baltzer I, Pinel C, Yugueros Marcos J, Kondori N, Potton L, Thiebaut-Bertrand A, Pelloux H, Cornet M.

Med Mycol. 2015 Sep;53(7):725-35. doi: 10.1093/mmy/myv037. Epub 2015 Jul 10.

PMID:
26162476
24.

Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.

van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, Chryssanthou E, Mellado E, Kidd SE, Tortorano AM, Dannaoui E, Gaustad P, Baddley JW, Uekötter A, Lass-Flörl C, Klimko N, Moore CB, Denning DW, Pasqualotto AC, Kibbler C, Arikan-Akdagli S, Andes D, Meletiadis J, Naumiuk L, Nucci M, Melchers WJ, Verweij PE.

Emerg Infect Dis. 2015 Jun;21(6):1041-4. doi: 10.3201/eid2106.140717.

25.

Molecular diagnosis of toxoplasmosis: value of the buffy coat for the detection of circulating Toxoplasma gondii.

Brenier-Pinchart MP, Capderou E, Bertini RL, Bailly S, Fricker-Hidalgo H, Varlet-Marie E, Murat JB, Sterkers Y, Touafek F, Bastien P, Pelloux H.

Diagn Microbiol Infect Dis. 2015 Aug;82(4):289-91. doi: 10.1016/j.diagmicrobio.2015.04.004. Epub 2015 Apr 24.

PMID:
25957458
26.

Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.

Robert-Gangneux F, Sterkers Y, Yera H, Accoceberry I, Menotti J, Cassaing S, Brenier-Pinchart MP, Hennequin C, Delhaes L, Bonhomme J, Villena I, Scherer E, Dalle F, Touafek F, Filisetti D, Varlet-Marie E, Pelloux H, Bastien P.

J Clin Microbiol. 2015 May;53(5):1677-84. doi: 10.1128/JCM.03282-14. Epub 2015 Mar 11.

27.

An in-house assay is superior to Sepsityper for direct matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry identification of yeast species in blood cultures.

Bidart M, Bonnet I, Hennebique A, Kherraf ZE, Pelloux H, Berger F, Cornet M, Bailly S, Maubon D.

J Clin Microbiol. 2015 May;53(5):1761-4. doi: 10.1128/JCM.03600-14. Epub 2015 Mar 11.

28.

Assessment of the IgA immunosorbent agglutination assay for the diagnosis of congenital toxoplasmosis on a series of 145 toxoplasmic seroconversions.

Murat JB, Souvignet A, Fricker-Hidalgo H, Brenier-Pinchart MP, Bost-Bru C, Pelloux H.

Clin Vaccine Immunol. 2015 Apr;22(4):456-8. doi: 10.1128/CVI.00666-14. Epub 2015 Feb 11.

29.

Severe Pneumocystis jirovecii pneumonia in an idiopathic CD4+ lymphocytopenia patient: case report and review of the literature.

Chumpitazi BFF, Flori P, Kern JB, Brenier-Pinchart MP, Larrat S, Minet C, Bouillet L, Maubon D, Pelloux H.

JMM Case Rep. 2014 Dec 1;1(4):e003434. doi: 10.1099/jmmcr.0.T00017. eCollection 2014 Dec.

30.

Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis.

Oliva A, Flori P, Hennequin C, Dubus JC, Reynaud-Gaubert M, Charpin D, Vergnon JM, Gay P, Colly A, Piarroux R, Pelloux H, Ranque S.

J Clin Microbiol. 2015 Jan;53(1):248-54. doi: 10.1128/JCM.02690-14. Epub 2014 Nov 12.

31.

Multicentric comparative assessment of the bio-evolution Toxoplasma gondii detection kit with eight laboratory-developed PCR assays for molecular diagnosis of congenital toxoplasmosis.

Filisetti D, Sterkers Y, Brenier-Pinchart MP, Cassaing S, Dalle F, Delhaes L, Pelloux H, Touafek F, Varlet-Marie E, Yera H, Candolfi E, Bastien P.

J Clin Microbiol. 2015 Jan;53(1):29-34. doi: 10.1128/JCM.01913-14. Epub 2014 Oct 22.

32.

Freezing and storage at -20 °C provides adequate preservation of Toxoplasma gondii DNA for retrospective molecular analysis.

Delhaes L, Filisetti D, Brenier-Pinchart MP, Pelloux H, Yéra H, Dalle F, Sterkers Y, Varlet-Marie E, Touafek F, Cassaing S, Bastien P.

Diagn Microbiol Infect Dis. 2014 Nov;80(3):197-9. doi: 10.1016/j.diagmicrobio.2014.08.007. Epub 2014 Aug 29.

PMID:
25241642
33.

Characterization and multicentric validation of a common standard for Toxoplasma gondii detection using nucleic acid amplification assays.

Varlet-Marie E, Sterkers Y, Brenier-Pinchart MP, Cassaing S, Dalle F, Delhaes L, Filisetti D, Pelloux H, Touafek F, Yera H, Bastien P.

J Clin Microbiol. 2014 Nov;52(11):3952-9. doi: 10.1128/JCM.01906-14. Epub 2014 Sep 3.

34.

Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis.

Chumpitazi BF, Lebeau B, Faure-Cognet O, Hamidfar-Roy R, Timsit JF, Pavese P, Thiebaut-Bertrand A, Quesada JL, Pelloux H, Pinel C.

Med Mycol. 2014 Jul;52(5):462-71. doi: 10.1093/mmy/myu018. Epub 2014 Jun 15.

PMID:
24934805
35.

Assembly of the novel five-component apicomplexan multi-aminoacyl-tRNA synthetase complex is driven by the hybrid scaffold protein Tg-p43.

van Rooyen JM, Murat JB, Hammoudi PM, Kieffer-Jaquinod S, Coute Y, Sharma A, Pelloux H, Belrhali H, Hakimi MA.

PLoS One. 2014 Feb 20;9(2):e89487. doi: 10.1371/journal.pone.0089487. eCollection 2014.

36.

miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain.

Cannella D, Brenier-Pinchart MP, Braun L, van Rooyen JM, Bougdour A, Bastien O, Behnke MS, Curt RL, Curt A, Saeij JP, Sibley LD, Pelloux H, Hakimi MA.

Cell Rep. 2014 Mar 13;6(5):928-37. doi: 10.1016/j.celrep.2014.02.002. Epub 2014 Feb 27.

37.

Usefulness of pan-fungal NASBA test for surveillance of environmental fungal contamination in a protected hematology unit.

Brenier-Pinchart MP, Abaibou H, Berendsen T, Szymanski G, Beghri M, Bailly S, Lasnet F, Thiebaut-Bertrand A, Mabilat C, Pelloux H.

Med Mycol. 2014 May;52(4):433-7. doi: 10.1093/mmy/myt017. Epub 2014 Jan 3.

PMID:
24577010
38.

Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry.

Camara B, Reymond E, Saint-Raymond C, Roth H, Brenier-Pinchart MP, Pinel C, Cadranel J, Ferretti G, Pelloux H, Pison C; Grenoble Aspergillus Committee.

Clin Respir J. 2015 Jan;9(1):65-73. doi: 10.1111/crj.12105. Epub 2014 Feb 17.

PMID:
24406138
39.

Human toxoplasmosis: which biological diagnostic tests are best suited to which clinical situations?

Murat JB, Hidalgo HF, Brenier-Pinchart MP, Pelloux H.

Expert Rev Anti Infect Ther. 2013 Sep;11(9):943-56. doi: 10.1586/14787210.2013.825441. Review.

PMID:
24053275
40.

A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation.

Braun L, Brenier-Pinchart MP, Yogavel M, Curt-Varesano A, Curt-Bertini RL, Hussain T, Kieffer-Jaquinod S, Coute Y, Pelloux H, Tardieux I, Sharma A, Belrhali H, Bougdour A, Hakimi MA.

J Exp Med. 2013 Sep 23;210(10):2071-86. doi: 10.1084/jem.20130103. Epub 2013 Sep 16.

41.

Prevalence of toxoplasmosis in France in 1998: is there a difference between men and women? At what age do children become infected?

Bellali H, Pelloux H, Villena I, Fricker-Hidalgo H, Le Strat Y, Goulet V.

Rev Epidemiol Sante Publique. 2013 Aug;61(4):311-7. doi: 10.1016/j.respe.2012.11.005. Epub 2013 Jul 1.

PMID:
23827774
42.

Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns.

Murat JB, Dard C, Fricker Hidalgo H, Dardé ML, Brenier-Pinchart MP, Pelloux H.

Clin Vaccine Immunol. 2013 Aug;20(8):1203-12. doi: 10.1128/CVI.00089-13. Epub 2013 Jun 5.

43.

Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L'ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H.

J Clin Microbiol. 2013 Jul;51(7):2103-11. doi: 10.1128/JCM.00169-13. Epub 2013 Apr 24.

44.

Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression.

Bougdour A, Durandau E, Brenier-Pinchart MP, Ortet P, Barakat M, Kieffer S, Curt-Varesano A, Curt-Bertini RL, Bastien O, Coute Y, Pelloux H, Hakimi MA.

Cell Host Microbe. 2013 Apr 17;13(4):489-500. doi: 10.1016/j.chom.2013.03.002.

45.

Flexible synthesis and evaluation of diverse anti-Apicomplexa cyclic peptides.

Traoré M, Mietton F, Maubon D, Peuchmaur M, Hilário FF, Pereira de Freitas R, Bougdour A, Curt A, Maynadier M, Vial H, Pelloux H, Hakimi MA, Wong YS.

J Org Chem. 2013 Apr 19;78(8):3655-75. doi: 10.1021/jo4001492. Epub 2013 Apr 4.

PMID:
23535138
46.

Borrelia crocidurae meningoencephalitis, West Africa.

Goutier S, Ferquel E, Pinel C, Bosseray A, Hoen B, Couetdic G, Bourahoui A, Lapostolle C, Pelloux H, Garnier M, Sertour N, Pelloux I, Pavese P, Cornet M.

Emerg Infect Dis. 2013 Feb;19(2):301-4. doi: 10.3201/eid1902.121325.

47.

Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies.

Villard O, Breit L, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E; French National Reference Center for Toxoplasmosis Network.

Clin Vaccine Immunol. 2013 Feb;20(2):197-204. doi: 10.1128/CVI.00356-12. Epub 2012 Dec 12.

48.

Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units?

Gibert P, Brudieu E, Timsit JF, Foroni L, Thiébaut-Bertrand A, Allenet B, Pelloux H, Brenier Pinchart MP.

J Hosp Infect. 2012 Dec;82(4):293-6. doi: 10.1016/j.jhin.2012.08.015. Epub 2012 Oct 24.

PMID:
23102819
49.

Comparative assessment of a commercial kit and two laboratory-developed PCR assays for molecular diagnosis of congenital toxoplasmosis.

Morelle C, Varlet-Marie E, Brenier-Pinchart MP, Cassaing S, Pelloux H, Bastien P, Sterkers Y.

J Clin Microbiol. 2012 Dec;50(12):3977-82. doi: 10.1128/JCM.01959-12. Epub 2012 Oct 3.

50.

Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results.

Murat JB, L'Ollivier C, Fricker Hidalgo H, Franck J, Pelloux H, Piarroux R.

Clin Vaccine Immunol. 2012 Nov;19(11):1838-43. doi: 10.1128/CVI.00333-12. Epub 2012 Sep 19.

Supplemental Content

Loading ...
Support Center